AGNPF (Grey Matters Health) EBITDA Margin %: 0.00% (As of Feb. 2026)


AGNPF Grey Matters Health Inc AGNPF
26 GF Score
Price $0.25
! 1 Warning Sign
View Full Analysis

What is Grey Matters Health EBITDA Margin %?

Grey Matters Health AGNPF -4.96% 26 EBITDA Margin % is 0.00% as of Feb. 2026. GuruFocus rates AGNPF with a GF Score™ of 26/100. The stock has 1 warning sign investors should review. Among 945 Biotechnology companies, Grey Matters Health ranks worse than 105820% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Grey Matters Health's EBITDA for the three months ended in Feb. 2026 was $-0.34 Mil. Grey Matters Health's Revenue for the three months ended in Feb. 2026 was $0.00 Mil. Therefore, Grey Matters Health's EBITDA margin for the quarter that ended in Feb. 2026 was 0.00%.

Grey Matters Health  (OTCPK:AGNPF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Grey Matters Health EBITDA Margin % Related Terms

Grey Matters Health EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Grey Matters Health's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grey Matters Health EBITDA Margin % Chart

Grey Matters Health Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Grey Matters Health Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

AGNPF vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, Grey Matters Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Grey Matters Health EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Grey Matters Health's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Grey Matters Health's EBITDA Margin % falls into.


AGNPF
26GF Score
Grey Matters Health Inc AGNPF
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Grey Matters Health EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Grey Matters Health's EBITDA Margin % for the fiscal year that ended in Aug. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Aug. 2025 )/Revenue (A: Aug. 2025 )
=-1.205/0
= %

Grey Matters Health's EBITDA Margin % for the quarter that ended in Feb. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Feb. 2026 )/Revenue (Q: Feb. 2026 )
=-0.34/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Grey Matters Health (AGNPF) has a EBITDA Margin % of 0.00% as of Feb. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Grey Matters Health and its competitors. According to the industry distribution chart, Grey Matters Health ranks #999999 out of 945 companies in the Biotechnology industry.
Is Grey Matters Health's EBITDA Margin % too high?
Grey Matters Health's current EBITDA Margin % is 0.00%. Based on the distribution chart, Grey Matters Health ranks #999999 out of 945 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Grey Matters Health has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Grey Matters Health's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Grey Matters Health ranks #999999 out of 945 companies for EBITDA Margin %. This places Grey Matters Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Grey Matters Health and its competitors. Grey Matters Health's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grey Matters Health stock overvalued right now?
Grey Matters Health (AGNPF) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Grey Matters Health's overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Grey Matters Health (AGNPF), the current EBITDA Margin % is 0.00% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Grey Matters Health Business Description

Other Exchanges GREY:Canada
Address 601 West Broadway, Suite 400, Vancouver, BC, CAN, V5Z 4C2
Grey Matters Health Inc is a drug repurposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations, and seeking new regulatory approvals in world-wide markets.
26GF Score

Get the complete analysis for AGNPF

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.25
Price